Skip to main content
. 2018 Nov 6;12(2):209–216. doi: 10.1016/j.tranon.2018.10.005

Table 1.

Colorectal Cancer Cell Line Panel

Cell Line Mutations
LoVo KRAS heterozygous G13D
FBXW7 heterozygous R505C
SW48 EGFR G719S
FBXW7 S668fs* (Frame_Shift_Del)
AKT2, FANCD2, FGFR1
HT29 BRAF (V600E, T119S)
PI3CA
FGFR3
RKO BRAF
PI3CA
BUB1 (Y259C)
DNMT3B (V616M)
BRAF (V600E)
TGFBR2 (V561A)
HSP90AA1 (D515N, N626D)
Caco2 P53
LS411N BRAF homozygous V600E
FBXW7 heterozygous P505H
EGFR (E34*, Q478E, T940A)
ErbB3, ErbB4 (P837G), DAPK (S1096N),
STAT3 (T178fs), Src (V380M)
HIP1, HIPK3, HDAC3, JAK2
cMET (T861)
DLD1 KRAS G13D
P53
PIK3CA E545K and D549N
HCT116 KRAS G13D
PIK3CA H1047R
cMet V237fs (Frame Shift)
FGFR1 and FGFR2
SW620 KRAS G12V
HCT116 KRAS G13D/+ (heterozygous)